Document is current
Any future updates will be listed below
-
Authors
Xu, Zheng-Gang
Liu, Yi-Wei
Ji, Yang
Cao, Shu-Ya
Wang, Tian
Wu, Huai-Yu
Tang, Wei-Wei
Wu, Xiao-Feng
Xia, Yong-Xiang
Xu, Qing
Wang, Ke
Wang, Xue-Hao
Ji, Gu-Wei
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82102150)
National Natural Science Foundation of China (82272791)
Natural Science Foundation of Jiangsu Province (BK20210968)
Major Program of National Natural Science Foundation of China (31930020)
Jiangsu Provincial Key Research and Development Program (BE2020708)
Major Program of Yili Clinical Medical Research Institute (yl2021zd04)
- License Information
-
More Information
Article History
Received: 1 March 2025
Accepted: 19 December 2025
First Online: 19 January 2026
Declarations
:
: This study was conducted in accordance with the Declaration of Helsinki and approved by the institutional review board of the First Affiliated Hospital of Nanjing Medical University (2019-SRFA-238), and informed consent was waived for retrospective data collection. The neoadjuvant cohort (NCT04297202) is a single-armed, open-labeled, phase II, prospective study that has been described previously [ ].
: Not applicable.
: The authors have no competing interests.
